Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

AIMS: To identify factors associated with achievement of glycated haemoglobin A1c (HbA1c) target at 24 weeks after commencing basal insulin therapy in individuals with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: Post‐hoc pooled analysis of 16 randomized, treat‐to‐target trials involving...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, David R., Landgraf, Wolfgang, Frier, Brian M., Zhang, Mei, Home, Philip D., Meneghini, Luigi, Bolli, Geremia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590355/
https://www.ncbi.nlm.nih.gov/pubmed/30520217
http://dx.doi.org/10.1111/dom.13607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590355/
https://www.ncbi.nlm.nih.gov/pubmed/30520217
http://dx.doi.org/10.1111/dom.13607

Ejemplares similares